Meeder Asset Management’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $15.2K | Buy |
57
+32
| +128% | +$8.66K | ﹤0.01% | 619 |
|
|
2025
Q4 | $6.27K | Sell |
25
-1
| -4% | -$266 | ﹤0.01% | 759 |
|
|
2025
Q3 | $7.46K | Sell |
26
-1
| -4% | -$268 | ﹤0.01% | 599 |
|
|
2025
Q2 | $7.09K | Buy |
27
+7
| +35% | +$1.71K | ﹤0.01% | 667 |
|
|
2025
Q1 | $4.66K | Sell |
20
-14
| -41% | -$3.4K | ﹤0.01% | 773 |
|
|
2024
Q4 | $7.8K | Sell |
34
-1,554
| -98% | -$356K | ﹤0.01% | 757 |
|
|
2024
Q3 | $355K | Sell |
1,588
-7
| -0.4% | -$1.54K | 0.02% | 192 |
|
|
2024
Q2 | $325K | Sell |
1,595
-3
| -0.2% | -$610 | 0.02% | 175 |
|
|
2024
Q1 | $349K | Buy |
+1,598
| New | +$352K | 0.02% | 243 |
|
|
2023
Q4 | – | Sell |
-865
| Closed | -$174K | – | 525 |
|
|
2023
Q3 | $174K | Buy |
+865
| New | +$182K | 0.01% | 316 |
|
|
2023
Q2 | – | Sell |
-45
| Closed | -$8.95K | – | 560 |
|
|
2023
Q1 | $8.95K | Sell |
45
-906
| -95% | -$186K | ﹤0.01% | 509 |
|
|
2022
Q4 | $192K | Sell |
951
-705
| -43% | -$138K | 0.02% | 412 |
|
|
2022
Q3 | $290K | Sell |
1,656
-128
| -7% | -$26.2K | 0.02% | 497 |
|
|
2022
Q2 | $359K | Sell |
1,784
-106
| -6% | -$22.6K | 0.02% | 464 |
|
|
2022
Q1 | $428K | Buy |
1,890
+749
| +66% | +$176K | 0.02% | 444 |
|
|
2021
Q4 | $308K | Buy |
1,141
+107
| +10% | +$26.5K | 0.03% | 272 |
|
|
2021
Q3 | $250K | Buy |
1,034
+170
| +20% | +$42.8K | 0.01% | 657 |
|
|
2021
Q2 | $205K | Buy |
864
+211
| +32% | +$48.1K | 0.01% | 719 |
|
|
2021
Q1 | $143K | Buy |
653
+194
| +42% | +$38.9K | 0.01% | 816 |
|
|
2020
Q4 | $80K | Buy |
459
+74
| +19% | +$12.8K | 0.02% | 471 |
|
|
2020
Q3 | $62K | Buy |
385
+79
| +26% | +$12.5K | ﹤0.01% | 912 |
|
|
2020
Q2 | $44K | Buy |
306
+114
| +59% | +$15.8K | ﹤0.01% | 951 |
|
|
2020
Q1 | $21K | Buy |
192
+24
| +14% | +$3.46K | ﹤0.01% | 1228 |
|
|
2019
Q4 | $24K | Sell |
168
-15
| -8% | -$2.17K | ﹤0.01% | 1292 |
|
|
2019
Q3 | $26K | Sell |
183
-37
| -17% | -$5.4K | ﹤0.01% | 1223 |
|
|
2019
Q2 | $33K | Buy |
+220
| New | +$30.7K | ﹤0.01% | 1071 |
|
|
2016
Q3 | – | Sell |
-3,154
| Closed | -$353K | – | 857 |
|
|
2016
Q2 | $353K | Buy |
+3,154
| New | +$339K | 0.03% | 488 |
|
|
2015
Q1 | – | Sell |
-13,019
| Closed | -$1.21M | – | 547 |
|
|
2014
Q4 | $1.21M | Buy |
13,019
+6,189
| +91% | +$547K | 0.15% | 172 |
|
|
2014
Q3 | $597K | Sell |
6,830
-52
| -0.8% | -$4.7K | 0.09% | 196 |
|
|
2014
Q2 | $606K | Buy |
6,882
+617
| +10% | +$53.4K | 0.09% | 175 |
|
|
2014
Q1 | $529K | Buy |
+6,265
| New | +$500K | 0.09% | 170 |
|
Other funds holding LH
VCM
VPM
Meeder Asset Management's LH Position: Q1 2026 in Review
Meeder Asset Management increased its Labcorp (LH) stake by 128% in Q1 2026, buying an estimated $8.66K and bringing the position to 57 shares worth $15.2K. The position accounts for ﹤0.01% of the portfolio, ranked #619.
Meeder Asset Management first reported a position in LH in Q1 2014 and has held it in 31 quarters since. The position peaked at $1.21M in Q4 2014. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.
- Meeder Asset Management held 57 shares of Labcorp worth $15.2K as of Q1 2026.
- Meeder Asset Management bought 32 Labcorp shares in Q1 2026, an estimated $8.66K.
- Labcorp made up ﹤0.01% of Meeder Asset Management's portfolio in Q1 2026, its #619 holding.
- Meeder Asset Management first reported a position in Labcorp in Q1 2014 and has held it in 31 quarters since.
- Meeder Asset Management's Labcorp position peaked at $1.21M in Q4 2014.
- 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.
Based on Meeder Asset Management's 13F filing for Q1 2026, filed 7 May 2026.